Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Use of Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
NCT05020028Phase 3Recruiting
- Sponsor
- NYU Langone Health
- Start
- Jun 2022
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in knee osteoarthritis (OA), sponsored by NYU Langone Health. Started Jun 2022; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05020028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05020028.